On Friday, November 29, 2019, the CRCHUM Conferences will host Michael Strong, distinguished university professor at Western university, scientist at Robarts research institute and president of the Canadian institutes of health research.
Over 77,000 Canadians are living with multiple sclerosis (MS), a disease whose causes still remain unknown. Presently, they have no hope for a cure.
On Friday, November 15, 2019, the CRCHUM Conferences will host Andrew McGuire, assistant member in the vaccine and infectious disease division at Fred Hutchinson cancer research center and affiliate assistant professor in the department of global healthy of the U
Uncoordinated movements, impaired speech caused by muscle weakness, diabetes and cardiomyopathy: Friedreich’s ataxia hits hard and early. This neurodegenerative orphan disease, for which no treatment exists, generally manifests between the ages of 5 and 15, initially affecting walking.
On Friday, November 8, 2019, the CRCHUM Conferences will host Catherine Lubetzki, professor in the epartment of Neurology of Sorbonne University and coordinator in the MS center at Salpêtrière Hospital,
Dr. Anne-Marie Mes-Masson, a principal scientist of the cancer axis, is the recipient of the 2019 Canadian Cancer Research Alliance (CCRA) Award for Exceptional Leadership in Cancer Research
In a series released on October 23rd, the prestigious scientific journal The Lancet called for a new international approach to drug use with the help of international experts including Dr. Julie Bruneau.
On Friday, November 1st, 2019, the CRCHUM Conferences will host Philippe Pibarot, full professor at the Faculty of medecine of the University Laval and director of the Cardiology research at the Institut Universitaire de Cardiologie et de Pneumologie de Québec (I
On Friday, October 25, 2019, the CRCHUM Conferences will host Jacob Estes, professor at Vaccine and Gene Therapy Institute (VGTI) and chief of the Division of Pathobiology & Immunology at Oregon National Primate Research Center (ONPRC).
